All Stories

  1. Langerhans-Zell-Histiozytose

    Article • January 2026, Thieme Publishing Group

    Professor Milen Minkov

  2. Tumoren der Schilddrüse

    Article • January 2026, Thieme Publishing Group

    Professor Milen Minkov

  3. Leukocyte Adhesion Defect Type I: Delayed Umbilical Cord Separation, a Surplus of Cells, and a Deficit of Defense

    Article • The Journal of Pediatrics, November 2025, Elsevier

    Professor Milen Minkov

  4. Disease response criteria in Langerhans cell histiocytosis: a global view

    Article • International Journal of Hematology, April 2025, Springer Science + Business Media

    Professor Milen Minkov

  5. The Diligent Lego Player with Talocalcaneal Callosities

    Article • The Journal of Pediatrics, February 2024, Elsevier

    Professor Milen Minkov

  6. The ECHO recommendations for dealing with vinblastine shortage affecting standard treatment of systemic Langerhans cell histiocytosis

    Article • Pediatric Blood & Cancer, January 2024, Wiley

    Professor Milen Minkov

  7. Therapiestrategien bei Kindern und Jugendlichen mit Langerhanszell Histiozytosen

    Article • Klinische Pädiatrie, September 2023, Thieme Publishing Group

    Professor Milen Minkov

  8. Aktualisierte AWMF Leitlinie zur Diagnostik und Therapie der Langerhanszell Histiozytose (LCH) im Kindes- und Jugendalter

    Article • Klinische Pädiatrie, September 2023, Thieme Publishing Group

    Professor Milen Minkov

  9. Clinicogenomic associations in childhood Langerhans cell histiocytosis: an international cohort study

    Article • Blood Advances, February 2023, American Society of Hematology

    Professor Milen Minkov

  10. Outcome of haematopoietic cell transplantation in children with lysosomal acid lipase deficiency: a study on behalf of the EBMT Inborn Errors Working Party

    Article • British Journal of Pharmacology, February 2023, Springer Science + Business Media

    Professor Milen Minkov

  11. Essential medicines for childhood cancer in Europe: a pan-European, systematic analysis by SIOPE

    Article • The Lancet Oncology, December 2022, Elsevier

    Professor Milen Minkov

  12. Concurrence of a kinase‐dead BRAF and an oncogenic KRAS gain‐of‐function mutation in juvenile xanthogranuloma

    Article • Pediatric Blood & Cancer, November 2022, Wiley

    Professor Milen Minkov

  13. Whole‐body magnetic resonance imaging for staging Langerhans cell histiocytosis in children and young adults

    Article • Pediatric Blood & Cancer, November 2022, Wiley

    Professor Milen Minkov

  14. Fröschlein im Mund: eine Blickdiagnose?

    Article • Wiener Medizinische Wochenschrift, September 2022, Springer Science + Business Media

    Professor Milen Minkov

  15. SARS-CoV-2 Associated Pediatric Inflammatory Multisystem Syndrome With a High Prevalence of Myocarditis – A Multicenter Evaluation of Clinical and Laboratory Characteristics, Treatment and Outcome

    Article • Frontiers in Pediatrics, June 2022, Frontiers

    Professor Milen Minkov

  16. Vemurafenib acts as a molecular on-off switch governing systemic inflammation in Langerhans cell histiocytosis

    Article • Blood Advances, February 2022, American Society of Hematology

    Professor Milen Minkov

  17. Additive Prognostic Impact of Gastrointestinal Involvement in Severe Multisystem Langerhans Cell Histiocytosis

    Article • The Journal of Pediatrics, October 2021, Elsevier

    Professor Milen Minkov

  18. Training von Basisreanimationsmaßnahmen (Newborn Life Support, Paediatric Basic Life Support)

    Article • Monatsschrift Kinderheilkunde, June 2021, Springer Science + Business Media

    Professor Milen Minkov

  19. EVOLUTION OF TREATMENT OF CHILDREN WITH LANGERHANS CELL HISTIOCYTOSIS

    Article • PEDIATRIA Journal named after G N SPERANSKY, May 2021, Pediatria, Ltd.

    Professor Milen Minkov

  20. Langerhans Cell Histiocytosis of the Orbit: Spectrum of Clinical and Imaging Findings

    Article • The Journal of Pediatrics, March 2021, Elsevier

    Professor Milen Minkov

  21. Novel Compound Heterozygous Mutations in Two Families With Bernard–Soulier Syndrome

    Article • Frontiers in Pediatrics, January 2021, Frontiers

    Professor Milen Minkov

  22. Stem cell transplantation for children with hemophagocytic lymphohistiocytosis: results from the HLH-2004 study

    Article • Blood Advances, August 2020, American Society of Hematology

    Professor Milen Minkov

  23. Hemolytic anemia due to the unstable hemoglobin Wien: manifestations and long-term course in the largest pedigree identified to date

    Article • Haematologica, February 2020, Ferrata Storti Foundation (Haematologica)

    Professor Milen Minkov

  24. The coming of age of Langerhans cell histiocytosis

    Article • Nature Immunology, December 2019, Springer Science + Business Media

    Professor Milen Minkov

  25. Vemurafenib for Refractory Multisystem Langerhans Cell Histiocytosis in Children: An International Observational Study

    Article • Journal of Clinical Oncology, November 2019, American Society of Clinical Oncology (ASCO)

    Professor Milen Minkov

  26. Epigenomics and Single-Cell Sequencing Define a Developmental Hierarchy in Langerhans Cell Histiocytosis

    Article • Cancer Discovery, July 2019, American Association for Cancer Research (AACR)

    Dr Christoph Bock, Professor Milen Minkov

  27. Low mortality and short‐term morbidity in very preterm infants in Austria 2011–2016

    Article • Acta Paediatrica, March 2019, Wiley

    Professor Milen Minkov

  28. Mycoplasma-pneumoniae -assoziierte Mukositis mit Hautbeteiligung - ein Fallbericht

    Article • JDDG Journal der Deutschen Dermatologischen Gesellschaft, February 2019, Wiley

    Professor Milen Minkov

  29. Successful Treatment with SCIG of a Child with Refractory Chronic ITP

    Article • Journal of Clinical Immunology, January 2019, Springer Science + Business Media

    Professor Milen Minkov

  30. Mycoplasma pneumoniae -associated mucositis with cutaneous involvement - a case report

    Article • JDDG Journal der Deutschen Dermatologischen Gesellschaft, December 2018, Wiley

    Professor Milen Minkov

  31. Longitudinal assessment of peripheral blood BRAFV600E levels in patients with Langerhans cell histiocytosis

    Article • Pediatric Research, November 2018, Springer Science + Business Media

    Professor Milen Minkov

  32. Langerhans cell histiocytosis in children

    Article • Journal of the American Academy of Dermatology, June 2018, Elsevier

    Professor Milen Minkov

  33. Langerhans cell histiocytosis in children

    Article • Journal of the American Academy of Dermatology, June 2018, Elsevier

    Professor Milen Minkov

  34. An update on the treatment of pediatric-onset Langerhans cell histiocytosis through pharmacotherapy

    Article • Expert Opinion on Pharmacotherapy, January 2018, Taylor & Francis

    Professor Milen Minkov

  35. Histiozytäre Erkrankungen

    Article • January 2018, Springer Science + Business Media

    Professor Milen Minkov

  36. Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study

    Article • Blood, December 2017, American Society of Hematology

    Professor Milen Minkov, scott montgomery

  37. Effective Immunological Guidance of Genetic Analyses Including Exome Sequencing in Patients Evaluated for Hemophagocytic Lymphohistiocytosis

    Article • Journal of Clinical Immunology, September 2017, Springer Science + Business Media

    Dr. Christian Klemann, Professor Milen Minkov

  38. A consensus review on malignancy-associated hemophagocytic lymphohistiocytosis in adults

    Article • Cancer, June 2017, Wiley

    Professor Milen Minkov

  39. Central Nervous System Langerhans Cell Histiocytosis

    Article • June 2017, Springer Science + Business Media

    Professor Milen Minkov

  40. Targeted inhibition of the MAPK pathway: emerging salvage option for progressive life-threatening multisystem LCH

    Article • Blood Advances, February 2017, American Society of Hematology

    Professor Milen Minkov

  41. The Non-Langerhans Cell Histiocytoses (Rare Histiocytoses) – Clinical Aspects and Therapeutic Approaches

    Article • Klinische Pädiatrie, November 2016, Thieme Publishing Group

    Professor Milen Minkov

  42. Insights into the pathogenesis of Langerhans cell histiocytosis

    Article • ImmunoTargets and Therapy, October 2016, Dove Medical Press

    Professor Milen Minkov

  43. Current treatment of Langerhans cell histiocytosis

    Article • Expert Opinion on Orphan Drugs, September 2016, Taylor & Francis

    Professor Milen Minkov

  44. Management of chronic immune thrombocytopenia in children and adolescents: lessons from an Austrian national cross-sectional study of 81 patients

    Article • Seminars in Hematology, April 2016, Elsevier

    Professor Milen Minkov

  45. Two Novel Missense Mutations and a 5bp Deletion in the Erythroid-Specific Promoter of thePKLRGene in Two Unrelated Patients With Pyruvate Kinase Deficient Transfusion-Dependent Chronic Nonspherocytic Hemolytic Anemia

    Article • Pediatric Blood & Cancer, January 2016, Wiley

    Professor Milen Minkov

  46. Cladribine and cytarabine in refractory multisystem Langerhans cell histiocytosis: results of an international phase 2 study

    Article • Blood, September 2015, American Society of Hematology

    Professor Milen Minkov

  47. Malignancy-associated haemophagocytic lymphohistiocytosis in children and adolescents

    Article • British Journal of Haematology, May 2015, Wiley

    Professor Milen Minkov

  48. Treatment of Langerhans cell histiocytosis: it is time to learn from the past

    Article • British Journal of Haematology, March 2015, Wiley

    Professor Milen Minkov

  49. Lack of bone lesions at diagnosis is associated with inferior outcome in multisystem langerhans cell histiocytosis of childhood

    Article • British Journal of Haematology, December 2014, Wiley

    Professor Milen Minkov

  50. Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panel

    Article • Haematologica, April 2014, Ferrata Storti Foundation (Haematologica)

    Professor Milen Minkov

  51. Polycythaemia-inducing mutations in the erythropoietin receptor (EPOR): mechanism and function as elucidated by epidermal growth factor receptor-EPOR chimeras

    Article • British Journal of Haematology, February 2014, Wiley

    Professor Milen Minkov

  52. Histiozytosen

    Article • January 2014, Springer Science + Business Media

    Professor Milen Minkov

  53. Polycythemia-Inducing Mutations In The Erythropoietin Receptor (EPOR): Mechanism and Function Elucidated By EGFR– EPOR Chimeras

    Article • Blood, November 2013, American Society of Hematology

    Professor Milen Minkov

  54. Genetic Basis of Congenital Erythrocytosis

    Article • Human Mutation, October 2013, Wiley

    Dr. Gennadiy G. Taradin, Professor Milen Minkov

  55. Sequential decisions on FAS sequencing guided by biomarkers in patients with lymphoproliferation and autoimmune cytopenia

    Article • Haematologica, July 2013, Ferrata Storti Foundation (Haematologica)

    Professor Milen Minkov

  56. Hypertrophic Obstructive Cardiomyopathy in an Infant With an Adrenocortical Tumor

    Article • PEDIATRICS, July 2013, American Academy of Pediatrics (AAP)

    Professor Milen Minkov

  57. Radiological features of thymic langerhans cell histiocytosis

    Article • Pediatric Blood & Cancer, June 2013, Wiley

    Dr Helmut Prosch, Professor Milen Minkov

  58. Therapy prolongation improves outcome in multisystem Langerhans cell histiocytosis

    Article • Blood, June 2013, American Society of Hematology

    Professor Milen Minkov

  59. Treatment of Epstein Barr virus-induced haemophagocytic lymphohistiocytosis with rituximab-containing chemo-immunotherapeutic regimens

    Article • British Journal of Haematology, May 2013, Wiley

    Professor Milen Minkov

  60. Ferritin concentrations correlate to outcome of hematopoietic stem cell transplantation but do not serve as biomarker of graft-versus-host disease

    Article • Annals of Hematology, April 2013, Springer Science + Business Media

    Professor Milen Minkov

  61. Stem cell transplantation after reduced-intensity conditioning for sickle cell disease

    Article • European Journal Of Haematology, February 2013, Wiley

    Professor Milen Minkov

  62. Notch is active in Langerhans cell histiocytosis and confers pathognomonic features on dendritic cells

    Article • Blood, December 2012, American Society of Hematology

    Professor Milen Minkov

  63. Langerhans cell histiocytosis (LCH): Guidelines for diagnosis, clinical work-up, and treatment for patients till the age of 18 years

    Article • Pediatric Blood & Cancer, October 2012, Wiley

    Dr Riccardo Haupt, Professor Milen Minkov

  64. Isolated cutaneous Langerhans cell histiocytosis in a premature baby: What is the optimal approach?

    Article • Pediatric Blood & Cancer, September 2012, Wiley

    Professor Milen Minkov

  65. Langerhans-Zell-Histiozytose

    Article • Monatsschrift Kinderheilkunde, September 2012, Springer Science + Business Media

    Professor Milen Minkov

  66. Pulmonary Involvement in Pediatric-Onset Multisystem Langerhans Cell Histiocytosis: Effect on Course and Outcome

    Article • The Journal of Pediatrics, July 2012, Elsevier

    Professor Milen Minkov

  67. Langerhans cell histiocytosis: pragmatic empirism on the road to rational cure

    Article • Expert Opinion on Pharmacotherapy, June 2012, Informa Healthcare

    Professor Milen Minkov

  68. Long‐term outcome of hypothalamic pituitary tumors in Langerhans cell histiocytosis

    Article • Pediatric Blood & Cancer, December 2011, Wiley

    Dr Helmut Prosch, Professor Milen Minkov

  69. Kopf- und Halstumore im Kindesalter

    Article • Pädiatrie & Pädologie, December 2011, Springer Science + Business Media

    Professor Milen Minkov

  70. Newly diagnosed immune thrombocytopenia in children and adults: a comparative prospective observational registry of the Intercontinental Cooperative Immune Thrombocytopenia Study Group

    Article • Haematologica, August 2011, Ferrata Storti Foundation (Haematologica)

    Professor Milen Minkov

  71. Variant alleles of cytokine genes influence risk and clinical course of Langerhans cell histiocytosis

    Article • British Journal of Haematology, August 2011, Wiley

    Professor Milen Minkov

  72. Multisystem Langerhans Cell Histiocytosis in Children

    Article • Pediatric Drugs, April 2011, Springer Science + Business Media

    Professor Milen Minkov

  73. Clinical and immunological overlap between autoimmune lymphoproliferative syndrome and common variable immunodeficiency

    Article • Clinical Immunology, December 2010, Elsevier

    Dr Sebastian Fuchs, Professor Milen Minkov

  74. Evaluating Bleeding Severity in Children with newly Diagnosed Immune Thrombocytopenia: A Pilot Study

    Article • Klinische Pädiatrie, November 2010, Thieme Publishing Group

    Professor Milen Minkov

  75. Novel TMPRSS6 mutations associated with iron-refractory iron deficiency anemia (IRIDA)

    Article • Human Mutation, March 2010, Wiley

    Professor Milen Minkov

  76. Transcobalamin II deficiency at birth

    Article • Molecular Genetics and Metabolism, November 2009, Elsevier

    Professor Milen Minkov

  77. Subcutaneous anti-d globulin application is a safe treatment option of immune thrombocytopenia in children

    Article • Annals of Hematology, October 2009, Springer Science + Business Media

    Professor Milen Minkov

  78. Diabetes insipidus in Langerhans cell histiocytosis: When is treatment indicated?

    Article • Pediatric Blood & Cancer, May 2009, Wiley

    Professor Milen Minkov

  79. Granulocyte Transfusions in Children and Young Adults

    Article • Journal of Pediatric Hematology/Oncology, March 2009, Wolters Kluwer Health

    Professor Milen Minkov

  80. A Syndrome with Congenital Neutropenia and Mutations inG6PC3

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, January 2009, New England Journal of Medicine (NEJM/MMS)

    Professor Milen Minkov

  81. Reactivations in Multisystem Langerhans Cell Histiocytosis: Data of the International LCH Registry

    Article • The Journal of Pediatrics, November 2008, Elsevier

    Professor Milen Minkov

  82. Clinical and molecular characterisation of a prospectively collected cohort of children and adolescents with polycythemia vera

    Article • British Journal of Haematology, June 2008, Wiley

    Professor Milen Minkov

  83. Improved outcome in multisystem Langerhans cell histiocytosis is associated with therapy intensification

    Article • Blood, March 2008, American Society of Hematology

    Professor Milen Minkov

  84. Bone marrow assessment in Langerhans cell histiocytosis

    Article • Pediatric Blood & Cancer, October 2007, Wiley

    Professor Milen Minkov

  85. Extramedullary plasmacytoma of the adenoids

    Article • Pediatric Blood & Cancer, January 2007, Wiley

    Professor Milen Minkov

  86. Importance of allogeneic T-cells for disease control after stem cell transplantation for high-risk Langerhans cell histiocytosis

    Article • Haematologica, January 2007, Ferrata Storti Foundation (Haematologica)

    Professor Milen Minkov

  87. Severe Anemia Owing to Occult Pulmonary Hemorrhage

    Article • Journal of Pediatric Hematology/Oncology, July 2006, Wolters Kluwer Health

    Professor Milen Minkov

  88. Central nervous system‐related permanent consequences in patients with Langerhans cell histiocytosis

    Article • Pediatric Blood & Cancer, February 2006, Wiley

    Dr Helmut Prosch, Professor Milen Minkov

  89. Critical issues concerning splenectomy for chronic idiopathic thrombocytopenic purpura in childhood

    Article • Pediatric Blood & Cancer, January 2006, Wiley

    Professor Milen Minkov

  90. Skelettbefall bei Langerhanszellhistiozytose

    Article • Monatsschrift Kinderheilkunde, January 2006, Springer Science + Business Media

    Professor Milen Minkov

  91. Central diabetes insipidus: Is it Langerhans cell histiocytosis of the pituitary stalk? A diagnostic pitfall

    Article • Pediatric Blood & Cancer, June 2005, Wiley

    Dr Helmut Prosch, Professor Milen Minkov

  92. Improved outcome of treatment-resistant high-risk Langerhans cell histiocytosis after allogeneic stem cell transplantation with reduced-intensity conditioning

    Article • British Journal of Pharmacology, June 2005, Springer Science + Business Media

    Professor Milen Minkov

  93. Modern Imaging Methods for the Assessment of Langerhans' Cell Histiocytosis—Associated Neurodegenerative Syndrome: Case Report

    Article • Journal of Child Neurology, March 2005, SAGE Publications

    Professor Milen Minkov

  94. Risk factors for diabetes insipidus in langerhans cell histiocytosis

    Article • Pediatric Blood & Cancer, January 2005, Wiley

    Professor Milen Minkov

  95. Histiocytosis following T-acute lymphoblastic leukemia: A BFM study

    Article • Leukemia & Lymphoma, January 2005, Taylor & Francis

    Professor Milen Minkov

  96. Langerhans cell histiocytosis in neonates

    Article • Pediatric Blood & Cancer, January 2005, Wiley

    Professor Milen Minkov

  97. Pineal gland abnormalities in Langerhans cell histiocytosis

    Article • Pediatric Blood & Cancer, September 2004, Wiley

    Professor Milen Minkov

  98. Central diabetes insipidus as presenting symptom of Langerhans cell histiocytosis

    Article • Pediatric Blood & Cancer, June 2004, Wiley

    Dr Helmut Prosch, Professor Milen Minkov

  99. Course and clinical impact of magnetic resonance imaging findings in diabetes insipidus associated with Langerhans cell histiocytosis

    Article • Pediatric Blood & Cancer, April 2004, Wiley

    Dr Helmut Prosch, Professor Milen Minkov

  100. Demonstration of CD1a positive cells in the cerebrospinal fluid—A clue to diagnosis of isolated Langerhans cell histiocytosis of the hypothalamic—pituitary axis?

    Article • Medical and Pediatric Oncology, September 2003, Wiley

    Dr Helmut Prosch, Professor Milen Minkov

  101. IVIG Treatment of Adenovirus Infection-Associated Macrophage Activation Syndrome in a Two-Year-Old Boy: Case Report and Review of the Literature

    Article • Pediatric Hematology and Oncology, September 2003, Taylor & Francis

    Professor Milen Minkov

  102. Immunosuppressive treatment for chemotherapy-resistant multisystem langerhans cell histiocytosis

    Article • Medical and Pediatric Oncology, January 2003, Wiley

    Professor Milen Minkov

  103. IVIG Treatment of Adenovirus Infection-Associated Macrophage Activation Syndrome in a Two-Year-Old Boy: Case Report and Review of the Literature

    Article • Pediatric Hematology and Oncology, January 2003, Taylor & Francis

    Professor Milen Minkov

  104. Response to initial treatment of multisystem langerhans cell histiocytosis: An important prognostic indicator

    Article • Medical and Pediatric Oncology, October 2002, Wiley

    Professor Milen Minkov

  105. Pattern and course of single-system disease in Langerhans cell histiocytosis data from the DAL-HX 83- and 90-study

    Article • Medical and Pediatric Oncology, January 2001, Wiley

    Professor Milen Minkov

  106. Statement of current majority practices in graft-versus-host disease prophylaxis and treatment in children

    Article • British Journal of Pharmacology, August 2000, Springer Science + Business Media

    Professor Milen Minkov

  107. Treatment of Multisystem Langerhans Cell Histiocytosis. Results of the DAL-HX 83 and DAL-HX 90 Studies

    Article • Klinische Pädiatrie, August 2000, Thieme Publishing Group

    Professor Milen Minkov

  108. Cyclosporine A therapy for multisystem Langerhans cell histiocytosis

    Article • Medical and Pediatric Oncology, November 1999, Wiley

    Professor Milen Minkov

  109. Cyclosporine A therapy for multisystem Langerhans cell histiocytosis

    Article • Medical and Pediatric Oncology, November 1999, Wiley

    Professor Milen Minkov

  110. Leucocyte transfusions from rhG-CSF or prednisolone stimulated donors for treatment of severe infections in immunocompromised neutropenic patients

    Article • British Journal of Haematology, September 1999, Wiley

    Professor Milen Minkov

  111. OCCURRENCE OF ACUTE NONLYMPHOBLASTIC LEUKEMIA IN TWO GIRLS AFTER TREATMENT OF RECURRENT, DISSEMINATED LANGERHANS CELL HISTIOCYTOSIS

    Article • Pediatric Hematology and Oncology, January 1999, Taylor & Francis

    Professor Milen Minkov

  112. Transplantation activities and treatment strategies in paediatric stem cell transplantation centres: a report from the EBMT Working Party on Paediatric Diseases

    Article • British Journal of Pharmacology, August 1998, Springer Science + Business Media

    Professor Milen Minkov

  113. A single Centre Experience with allogeneic Stem Cell Transplantation for Severe Aplastic Anaemia in Childhood

    Article • Klinische Pädiatrie, July 1997, Thieme Publishing Group

    Professor Milen Minkov